Menu
Not yet recruiting NCT07147582

Effect of Transcranial Alternating Current Stimulation on Sleep Disorder and Anxiety in Elderly Population

No phase Interventional Chronic Sleep Disorders Anxiety Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Transcranial alternating current stimulation with two electrodes placed on scalp.
Who it may be relevant to
Registry conditions: Chronic Sleep Disorders, Anxiety Disorder. Basic parameters: from 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Sleep disorders and anxiety are complicated disorders affecting population especially elderly population, therefore treating these disorders will have positive impact on population production and quality of life.

Detailed description

Alternating current cranial stimulation will improve brain waves frequency so that will have positive effect on sleep disorders and anxiety on elderly population.

Interventions

  • Other Transcranial alternating current stimulation with two electrodes placed on scalp
    Transcranial alternating current stimulation with anode and cathode electrodes and frequency ranged from 8 to 13 HZ

Primary outcome measures

  • Sleep quality [Time frame: before treatment and after 12 weeks]
Secondary outcome measures (1)
  • Anxiety [Time frame: before treatment and after 12 weeks of treatment]

Eligibility criteria

Inclusion criteria

-healthy elderly adult aged more than 60 years old, both sex, and suffering from insomnia and sleep disorders

Exclusion criteria

  • neurological and vascular diseases.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Cairo

Identifiers

NCT: NCT07147582 · SREC.PT.SUE(14)625

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗